Blueberries are more effective at killing cancer than

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
255
Blueberries are more effective at killing cancer than radiotherapy

I hope it is true, I eat a lot of them, but comparing it to radiotherapy does not mean it kills it period?

https://www.alternativemedicine.news/2020-05-...erapy.html

Blueberries are one of the richest natural sources of antioxidants. Current research suggests that one of these antioxidants can effectively inhibit cancer cell growth.

Published in Evidence-Based Complementary and Alternative Medicine, a groundbreaking study found that an antioxidant in blueberries called pterostilbene can prevent radiation-induced cancer cell growth and tumor formation in the liver.

The repercussions of conventional cancer treatments
Despite scientific advancements in cancer research and treatment, cancer remains one of the leading causes of death worldwide. The extensive use of radiation, steroids and other powerful drugs has caused cancer cells to become resistant, thus complicating treatment for patients.

Radiation therapy, a type of conventional cancer treatment, uses high doses of radiation to kill cancer cells and shrink tumors. However, existing radiation therapies often fail to eradicate the tumors themselves, thus resulting in disease relapse. Such is the case for radiation therapies against hepatocellular carcinoma (HCC), or liver cancer, one of the most common types of cancer around the world.

Several cancer studies have also long since proven that radiation therapies tend to destroy healthy cells in the body, thus contributing to cellular damage and low patient survival rates. Because of this significant and harmful side effect, most of the ongoing research on cancer treatment focuses on mitigating cancer cell invasion without affecting other cells.

Pterostilbene as a cancer-fighting antioxidant
A team of researchers from Taipei Medical University and Academia Sinica in Taiwan found that the antioxidant pterostilbene found in grapes and blueberries can inhibit cancer cell invasion, a phenomenon linked to radiation exposure.

For the experiment, the team treated lab-grown HCC cancer stem cells with increasing concentrations of pterostilbene prior to gamma irradiation.

The researchers found that pterostilbene suppressed the proliferation of cancer stem cells due to irradiation. In fact, the number of pre-treated cancer stem cells was down to 0.7 percent compared to the 16.5 percent in the control group. This suggests that in high doses, pterostilbene can eliminate cancer cells completely.

In addition, pterostilbene disrupted the formation of tumors and induced apoptosis, or programmed cell death, in the cancer stem cells. All things considered, pterostilbene appeared to inhibit radiation-induced cancer cell growth and suppress tumor formation.

Based on their findings, the researchers thus concluded that pterostilbene in blueberries can reduce and eliminate cancer cells better than irradiation. The experiment also provided strong evidence that irradiation stimulated cancer cell invasion and tumor formation.

Proven health benefits of antioxidants in blueberries
Besides their cancer-fighting properties, the powerful antioxidants in blueberries are also hailed for their numerous health benefits. Here are some of them:

Blueberries enhance heart health

Blueberries contain antioxidants called anthocyanins that prevent inflammation and cellular damage linked to cholesterol buildup. These antioxidants also help lower systolic and diastolic blood pressure, thus reducing the risk of heart disease, stroke and heart attack.

Blueberries protect against sun damage

Anthocyanins also protect skin cells from cellular damage due to sun exposure, which can accelerate aging and trigger the appearance of wrinkles and dark spots. Sun-damaged skin is also more susceptible to skin cancer and other skin conditions.

Blueberries prevent bone loss

Blueberries are also rich in polyphenols. These plant compounds have potent antioxidant properties that help maintain strong bones.

Blueberries improve cognitive health

Anthocyanins neutralize unstable molecules called free radicals that damage brain cells and cause inflammation. (Related: Blueberries are bursting with various antioxidants that reduce the risk of dementia.)

Blueberries regulate blood sugar

Anthocyanins also guard against inflammation due to high blood sugar. These antioxidants also help prevent spikes in blood sugar levels after meals.

Blueberries have powerful antioxidants and plant compounds that make them one of the healthiest superfoods for the treatment and prevention of cancer and other chronic diseases. Visit Blueberries.news to learn more.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Testing Grounds: Navigating PRN Test Insights

Updated Category News Views 1

Deciphering the PRN Tester Repetition Today we're staring at what feels like déjà vu—a simple PR test peppered with the classic sentence about a fox and a dog. It's like someone left the 'repeat' function stuck on during a slow day at the office. But hey, let’s dig in. Is there something more behind this repetitive text, or are we grumbling at a wall? Unpacking the...

Continue Reading
TECNO's Modular Phone and Mini-PC Win Big at IFA 2026

Updated Category News Views 1

The Tale of Two Game-Changers TECNO has just scooped up two big-time awards, and I'm here to break it down like no glossy magazine ever could. Picture this: a brand that knows how to keep its foot on the innovation pedal and doesn't shy away from shaking up the tech world. TECNO's got the goods, claiming two prestigious IFA Global Product Technology Innovation Awards this...

Continue Reading
HKC and KOORUI Shine Bright at 2026 Berlin Awards

Updated Category News Views 3

Display Titans Take Center Stage in Berlin Look, in this game of display tech, you either adapt or get left in the dust. At the 2026 Global Product Technology Innovation Awards in Berlin, we saw two names rise to the top—HKC and its acclaimed brand KOORUI. They didn't just show up; they grabbed the spotlight with two major honors. Award Spotlights: A Breakdown HKC took...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 2

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
LiberNovo Spotlights Ergonomic Seating at Berlin's IFA 2026

Updated Category News Views 1

LiberNovo Sets the Stage at IFA 2026 If you're poking around Berlin this September, the Messe Berlin is the place to be, especially for those keeping tabs on the consumer tech world. LiberNovo, the ergonomic seating company you might not have had on your radar, is out here making noise. They're throwing down the gauntlet with the Maxis Series, promising a better deal for...

Continue Reading
Affleck Joins Aflac in Unlikely Yet Fitting Alliance

Updated Category News Views 2

A Partnership Born from a Punning Connection Look, in this world of insurance and Hollywood glitz, it's not every day you see Ben Affleck sharing the screen with a talking duck. But here we are. Aflac—the giant in supplemental health insurance—and Ben Affleck have cozied up for a series of ads under Affleck’s direction, breathing life into what started as nothing...

Continue Reading
Hims & Hers Faces Legal Storm Over Alleged Privacy Breaches

Updated Category News Views 4

Legal Storms Brew Over Alleged Privacy Breaches Well, here we go again, folks. Just when you think the waters are calming, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself in the thick of a nasty securities fraud class action lawsuit. Allegedly they've been less than honest with their customers' health info—something about sneaking around with people's sensitive data...

Continue Reading
Evolve & ELITEWHEELS: Shifting Gears in European Cycling

Updated Category News Views 3

Revving Up for the European Cycling Scene There's something about the open road and the whirr of wheels that gets blood pumping—maybe it's the competition, maybe it's the gear. Either way, this year's Italian Bike Festival is turning the Misano World Circuit into a battleground for cycling's elite, with evolve and ELITEWHEELS charging at the forefront. They're not just...

Continue Reading
Virterion Surges Ahead in VPS Racing With Reliable Hosting

Updated Category News Views 3

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...

Continue Reading
Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 1

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading

Top 5 Most Recently Viewed Articles

Talisker Resources Successfully Closes Gold-Linked Note Deal

Updated Category News Views 49

Talisker Resources Announces Successful Financing Initiative Talisker Resources Ltd. (TSK) has made headlines with the completion of its latest financing venture involving $1.33 million through the issuance of gold-linked notes. This strategic move is set to propel the progress of Talisker's flagship project, the Bralorne Gold Project, which is currently undergoing...

Continue Reading
FDA Approves Novartis' Kisqali, Expanding Breast Cancer Treatment

Updated Category News Views 133

FDA Approves Novartis' Kisqali: A Major Step Forward in Breast Cancer Care Novartis (NYSE: NVS) has reached a crucial milestone with the FDA's approval of Kisqali (ribociclib), now available for a broader group of patients facing early-stage breast cancer. This approval represents a significant leap in treating hormone receptor-positive/human epidermal growth factor...

Continue Reading
Mounting Challenges for Mobileye N.V: Insights into Stock Outlook

Updated Category News Views 101

Mobileye Faces Downgrade as Transition Year Approaches Recently, UBS has revised its outlook on Mobileye N.V (NASDAQ:MBLY), a leader in autonomous driving technologies. The firm has downgraded the stock from Buy to Neutral, with a lowered price target of $14.00, decreasing from an earlier target of $20.00. This decision is primarily due to the company's current struggles,...

Continue Reading
Plans for Spending Cuts and Subsidy Eliminations Revealed

Updated Category News Views 118

Plans for Federal Spending Cuts and Subsidy Eliminations John Paulson, a billionaire investor known for his connections with former President Donald Trump, has outlined his strategy for significant federal spending reductions if he were to be appointed as Treasury Secretary. Collaborating with Elon Musk, Paulson seeks to minimize government expenditures, particularly by...

Continue Reading
Brazil’s Finance Minister Prepares for Key Fiscal Announcements

Updated Category News Views 35

Brazil's Finance Minister Prepares for Key Fiscal Announcements Brazil's Finance Minister Fernando Haddad has recently indicated that significant fiscal measures aimed at supporting the country’s financial framework might be unveiled shortly. This announcement comes as the government approaches the final stages of preparation for what could be a pivotal moment in...

Continue Reading